Literature DB >> 9603086

The conundrum of the Glasgow Coma Scale in intubated patients: a linear regression prediction of the Glasgow verbal score from the Glasgow eye and motor scores.

W Meredith1, R Rutledge, S M Fakhry, S Emery, S Kromhout-Schiro.   

Abstract

BACKGROUND: The Glasgow Coma Scale (GCS), which is the foundation of the Trauma Score, Trauma and Injury Severity Score, and the Acute Physiology and Chronic Health Evaluation scoring systems, requires a verbal response. In some series, up to 50% of injured patients must be excluded from analysis because of lack of a verbal component for the GCS. The present study extends previous work evaluating derivation of the verbal score from the eye and motor components of the GCS.
METHODS: Data were obtained from a state trauma registry for 24,565 unintubated patients. The eye and motor scores were used in a previously published regression model to predict the verbal score: Derived Verbal Score = -0.3756 + Motor Score * (0.5713) + Eye Score * (0.4233). The correlation of the actual and derived verbal and GCS scales were assessed. In addition the ability of the actual and derived GCS to predict patient survival in a logistic regression model were analyzed using the PC SAS system for statistical analysis. The predictive power of the actual and the predicted GCS were compared using the area under the receiver operator characteristic curve and Hosmer-Lemeshow goodness-of-fit testing.
RESULTS: A total of 24,085 patients were available for analysis. The mean actual verbal score was 4.4 +/- 1.3 versus a predicted verbal score of 4.3 +/- 1.2 (r = 0.90, p = 0.0001). The actual GCS was 13.6 + 3.5 versus a predicted GCS of 13.7 +/- 3.4 (r = 0.97, p = 0.0001). The results of the comparison of the prediction of survival in patients based on the actual GCS and the derived GCS show that the mean actual GCS was 13.5 + 3.5 versus 13.7 + 3.4 in the regression predicted model. The area under the receiver operator characteristic curve for predicting survival of the two values was similar at 0.868 for the actual GCS compared with 0.850 for the predicted GCS.
CONCLUSIONS: The previously derived method of calculating the verbal score from the eye and motor scores is an excellent predictor of the actual verbal score. Furthermore, the derived GCS performed better than the actual GCS by several measures. The present study confirms previous work that a very accurate GCS can be derived in the absence of the verbal component.

Entities:  

Mesh:

Year:  1998        PMID: 9603086     DOI: 10.1097/00005373-199805000-00016

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  37 in total

Review 1.  Evaluation of coma: a critical appraisal of popular scoring systems.

Authors:  Joshua Kornbluth; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

2.  Prolonged emergency department length of stay is not associated with worse outcomes in patients with intracerebral hemorrhage.

Authors:  Jonathan Elmer; Daniel J Pallin; Shan Liu; Catherine Pearson; Yuchiao Chang; Carlos A Camargo; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

Review 3.  [Glasgow Coma Scale in traumatic brain injury].

Authors:  C Heim; P Schoettker; D R Spahn
Journal:  Anaesthesist       Date:  2004-12       Impact factor: 1.041

4.  Accuracy of point-of-care blood glucose measurements in critically ill patients in shock.

Authors:  Carlo Jan Pati-An Garingarao; Myrna Buenaluz-Sedurante; Cecilia Alegado Jimeno
Journal:  J Diabetes Sci Technol       Date:  2014-06-08

5.  A pilot study evaluating a simple cardiac dysfunction score to predict complications and survival among critically-ill patients with traumatic brain injury.

Authors:  Patric W Gibbons; Robert J Goldberg; Susanne Muehlschlegel
Journal:  J Crit Care       Date:  2019-08-08       Impact factor: 3.425

6.  Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries.

Authors:  Kristina E Rudd; Christopher W Seymour; Adam R Aluisio; Marc E Augustin; Danstan S Bagenda; Abi Beane; Jean Claude Byiringiro; Chung-Chou H Chang; L Nathalie Colas; Nicholas P J Day; A Pubudu De Silva; Arjen M Dondorp; Martin W Dünser; M Abul Faiz; Donald S Grant; Rashan Haniffa; Nguyen Van Hao; Jason N Kennedy; Adam C Levine; Direk Limmathurotsakul; Sanjib Mohanty; François Nosten; Alfred Papali; Andrew J Patterson; John S Schieffelin; Jeffrey G Shaffer; Duong Bich Thuy; C Louise Thwaites; Olivier Urayeneza; Nicholas J White; T Eoin West; Derek C Angus
Journal:  JAMA       Date:  2018-06-05       Impact factor: 56.272

7.  The Estimated Verbal GCS Subscore in Intubated Traumatic Brain Injury Patients: Is it Really Better?

Authors:  Katarina Cheng; Ribal Bassil; Raphael Carandang; Wiley Hall; Susanne Muehlschlegel
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

8.  Fluid balance, complications, and brain tissue oxygen tension monitoring following severe traumatic brain injury.

Authors:  Jeffrey J Fletcher; Karen Bergman; Paul A Blostein; Andreas H Kramer
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

9.  Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine Design.

Authors:  Surender Khurana; Supriya Ravichandran; Megan Hahn; Elizabeth M Coyle; Spencer W Stonier; Samantha E Zak; Jason Kindrachuk; Richard T Davey; John M Dye; Daniel S Chertow
Journal:  Cell Host Microbe       Date:  2020-02-12       Impact factor: 21.023

10.  Quantification of Iodine Leakage on Dual-Energy CT as a Marker of Blood-Brain Barrier Permeability in Traumatic Hemorrhagic Contusions: Prediction of Surgical Intervention for Intracranial Pressure Management.

Authors:  U K Bodanapally; K Shanmuganathan; Y P Gunjan; G Schwartzbauer; R Kondaveti; T R Feiter
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.